Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 6, 2023; 11(4): 909-917
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.909
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.909
Variables | Patient |
Baseline characteristics | |
Age (yr) | 36 |
Etiology/Trigger | SLE and multiple infections |
HLH- directed therapies | VP16 and methylprednisolone |
HLH- 2004 criteria at diagnosis (ref.: Henter-2007) | |
Fever | Y |
Splenomegaly | N |
Cytopenia, affecting 2 of 3 lineages in the peripheral blood | |
Hemoglobin concentration < 9 g/dL | Y |
Neutrophil count < 1.0 × 109/L | Y |
Platelet count < 100 × 109/L | Y |
Hypertriglyceridemia (fasting ≥ 3.0 mmol/L) and/or hypofibrinogenemia (≤ 150 mg/dL) | Y |
Hemophagocytosis in bone marrow or spleen or lymph nodes (no evidence of malignancy) | N |
Low or absent natural killer cell activity | N/A |
Ferritin ≥ 500 ng/mL | Y |
Soluble cluster of differentiation 25 (i.e. soluble interleukin 2 receptor) ≥ 2400 U/mL | N |
- Citation: Peng LY, Liu JB, Zuo HJ, Shen GF. Unusual presentation of systemic lupus erythematosus as hemophagocytic lymphohistiocytosis in a female patient: A case report. World J Clin Cases 2023; 11(4): 909-917
- URL: https://www.wjgnet.com/2307-8960/full/v11/i4/909.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i4.909